KIMBERLY KALOVCAK: Open Payments
NPI 1942772405 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 64 payments from 15 companies in 2025. Trend: 2023 $1,697 · 2024 $2,601 · 2025 $1,258
Food & beverage: $1,258
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $192 |
| ABBVIE INC. | 9 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $173 |
| Ardelyx, Inc. | 5 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $111 |
| Aimmune Therapeutics, Inc. | 5 | $82 |
| Madrigal Pharmaceuticals | 3 | $79 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Celltrion USA Inc. | 3 | $60 |
| Ferring Pharmaceuticals Inc. | 2 | $45 |
Products named: TREMFYA, IBSRELA, ENTYVIO, XIFAXAN, RINVOQ, DUPIXENT, ZENPEP, REZDIFFRA.
Industry payments across PA — which companies pay providers there.
